Overall | Cochrane | Non-Cochrane | ||
---|---|---|---|---|
N (%) | n (%) | n (%) | p Value* | |
Percentage of disclosures that specify the following characteristics of the institutional financial COI | ||||
Source | 17 (90%) | 5 (71%) | 12 (100%) | 0.123 |
Specify that a source produces one of the products subject of the SR† | 1 (6%) | 1 (20%) | 0 (0%) | 0.294 |
Specify that a source produces products not subject of the SR but under the same therapeutic area† | 0 (0%) | 0 (0%) | 0 (0%) | NA |
Monetary value | 1 (5%) | 0 (0%) | 1 (8%) | 1.000 |
Duration | 3 (16%) | 0 (0%) | 3 (25%) | 0.263 |
During conduct of the study‡ | 3 (100%) | NA | 3 (100%) | NA |
1 year‡ | 0 (0%) | 0 (0%) | ||
2 years‡ | 0 (0%) | 0 (0%) | ||
3 years‡ | 0 (0%) | 0 (0%) | ||
4 years‡ | 0 (0%) | 0 (0%) | ||
5 years‡ | 0 (0%) | 0 (0%) | ||
More than 5 years‡ | 0 (0%) | 0 (0%) |
*p Value for the difference between Cochrane and non-Cochrane systematic reviews.
†Calculated using N=17 as the denominator in the overall group (5 and 12 in the two respective subgroups).
‡Calculated using N=3 as the denominator in the overall group (0 and 3 in the two respective subgroups).
COI, conflict of interest; NA, not applicable; SR, systematic review.